门节约性大动脉根替换与再植入与重塑:一个元分析
Michel Pompeu Sá1, Xander Jacquemyn2, Ahmed K Awad3
1Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
The Annals of thoracic surgery
|October 13, 2023
概括
与再植入一起的门节约性大动脉根置换 (VSARR) 提供了比重塑更好的生存率和更低的再干预率. 再植入显示出早期生存优势,四年后没有显著差异.
科学领域:
- 心血管外科心血管外科
- 胸部外科手术 胸部外科手术
- 大动脉外科手术
背景情况:
- 讨论了节约性大动脉根置换 (VSARR) 技术的长期结果,特别是重新植入与重塑的结果.
- 大动脉根手术是复杂的,患者的结果取决于所选择的手术方法.
研究的目的:
- 为了比较使用再植入技术与重塑技术的门节约性大动脉根置换 (VSARR) 的长期疗效.
- 评估两种VSARR方法之间的总生存率差异和重新干预的需要.
主要方法:
- 对Kaplan-Meier数据的综合元分析,这些数据来自到2022年12月31日发表的比较研究.
- 包括15项研究,共3044名接受VSARR的患者.
主要成果:
- 经过重塑的VSARR治疗的患者具有明显更高的全因死亡风险 (HR,1.54) 和重新干预 (HR,1.49).
- 里程碑式的分析显示,重塑组的生存率在前4年内较低 (HR,2.15),之后没有显著差异.
- 年龄,性别或特定并发症等共变量对观察到的效应没有显著的影响.
结论:
- 与重新植入的门节约性大动脉根置换 (VSARR) 与较高的整体存活率和较低的重新干预需求有关,与重塑技术相比.
- 重新植入的生存益处在早期随访期 (长达4年) 中最为明显.
更多相关视频
相关概念视频
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12


